Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), An Orally Available Syk Inhibitor

Published 2023 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), An Orally Available Syk Inhibitor
Authors
Keywords
-
Journal
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Volume -, Issue -, Pages JPET-AR-2023-001752
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Online
2023-11-03
DOI
10.1124/jpet.123.001752

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.